Immunotherapy for infectious diseases in haematological immunocompromise.

about

Effect of ArtinM on Human Blood Cells During Infection With Paracoccidioides brasiliensis.

P2860

Q54205003-F76E5B7F-AC20-4F23-9C48-8DF4C7C07126

P2860

Immunotherapy for infectious diseases in haematological immunocompromise.

Item

http://www.wikidata.org/entity/Q39215653

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immunotherapy for infectious diseases in haematological immunocompromise.

@en

Immunotherapy for infectious diseases in haematological immunocompromise.

@nl

type

Item

label

Immunotherapy for infectious diseases in haematological immunocompromise.

@en

Immunotherapy for infectious diseases in haematological immunocompromise.

@nl

prefLabel

Immunotherapy for infectious diseases in haematological immunocompromise.

@en

Immunotherapy for infectious diseases in haematological immunocompromise.

@nl

P1476

Immunotherapy for infectious diseases in haematological immunocompromise.

@en

P2093

Chris Eades

http://www.w3.org/2001/XMLSchema#string

Katayoun Rezvani

http://www.w3.org/2001/XMLSchema#string

Maria-Teresa Cutino-Moguel

http://www.w3.org/2001/XMLSchema#string

P2860

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Potential uses of probiotics in clinical practice

G-CSF and GM-CSF in Neutropenia

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Monoclonal antibody therapies against anthrax

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma

P304

348-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14595

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Darius Armstrong-James

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28369798

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Immunotherapy for infectious diseases in haematological immunocompromise.

about

P2860

P2860

Immunotherapy for infectious diseases in haematological immunocompromise.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921